US20060239921A1 - Real time vascular imaging during solid organ transplant - Google Patents
Real time vascular imaging during solid organ transplant Download PDFInfo
- Publication number
- US20060239921A1 US20060239921A1 US11/114,501 US11450105A US2006239921A1 US 20060239921 A1 US20060239921 A1 US 20060239921A1 US 11450105 A US11450105 A US 11450105A US 2006239921 A1 US2006239921 A1 US 2006239921A1
- Authority
- US
- United States
- Prior art keywords
- vessel
- dye
- energy
- organ
- fluorescent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000000056 organ Anatomy 0.000 title claims abstract description 82
- 238000003384 imaging method Methods 0.000 title claims abstract description 45
- 239000007787 solid Substances 0.000 title abstract description 25
- 230000002792 vascular Effects 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 58
- 239000000975 dye Substances 0.000 claims description 52
- 239000007850 fluorescent dye Substances 0.000 claims description 34
- 230000003872 anastomosis Effects 0.000 claims description 12
- 229960004657 indocyanine green Drugs 0.000 claims description 11
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical group [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 claims description 11
- 210000000496 pancreas Anatomy 0.000 claims description 11
- 210000004185 liver Anatomy 0.000 claims description 10
- 210000002216 heart Anatomy 0.000 claims description 8
- 210000003734 kidney Anatomy 0.000 claims description 8
- 210000000626 ureter Anatomy 0.000 claims description 8
- 210000004072 lung Anatomy 0.000 claims description 7
- 210000001367 artery Anatomy 0.000 claims description 5
- 210000003462 vein Anatomy 0.000 claims description 5
- 210000004204 blood vessel Anatomy 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 238000002329 infrared spectrum Methods 0.000 claims description 3
- 210000000277 pancreatic duct Anatomy 0.000 claims description 3
- 210000001147 pulmonary artery Anatomy 0.000 claims description 3
- 210000003492 pulmonary vein Anatomy 0.000 claims description 3
- 210000000709 aorta Anatomy 0.000 claims description 2
- 230000001746 atrial effect Effects 0.000 claims description 2
- 210000000013 bile duct Anatomy 0.000 claims description 2
- 210000002767 hepatic artery Anatomy 0.000 claims description 2
- 210000003240 portal vein Anatomy 0.000 claims description 2
- 230000002685 pulmonary effect Effects 0.000 claims description 2
- 210000002254 renal artery Anatomy 0.000 claims description 2
- 210000002796 renal vein Anatomy 0.000 claims description 2
- 210000001631 vena cava inferior Anatomy 0.000 claims description 2
- 210000002620 vena cava superior Anatomy 0.000 claims description 2
- 210000002989 hepatic vein Anatomy 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 230000037396 body weight Effects 0.000 description 5
- 239000000969 carrier Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229920002994 synthetic fiber Polymers 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 210000005166 vasculature Anatomy 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 description 1
- XQMVBICWFFHDNN-UHFFFAOYSA-N 5-amino-4-chloro-2-phenylpyridazin-3-one;(2-ethoxy-3,3-dimethyl-2h-1-benzofuran-5-yl) methanesulfonate Chemical compound O=C1C(Cl)=C(N)C=NN1C1=CC=CC=C1.C1=C(OS(C)(=O)=O)C=C2C(C)(C)C(OCC)OC2=C1 XQMVBICWFFHDNN-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 108010004469 allophycocyanin Proteins 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical group O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- DVGHHMFBFOTGLM-UHFFFAOYSA-L fluorogold Chemical compound F[Au][Au]F DVGHHMFBFOTGLM-UHFFFAOYSA-L 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229930187593 rose bengal Natural products 0.000 description 1
- 229940081623 rose bengal Drugs 0.000 description 1
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 210000002563 splenic artery Anatomy 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0045—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
- A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
- A61K49/0043—Fluorescein, used in vivo
Definitions
- the invention relates generally to the field of medical imaging. Certain embodiments of the invention provide methods for imaging of vasculature in a subject. Certain other embodiments provide systems which are useful for imaging vasculature in a subject.
- Imaging of biological tissues and organs assists doctors in both diagnosis and treatment.
- a variety of medical techniques which are suitable for imaging biological tissues and organs are known. These include traditional x-rays, ultra-sound, as well as magnetic resonance imaging (MRI), and computerized tomography (CT).
- MRI magnetic resonance imaging
- CT computerized tomography
- dyes used in medical imaging have also been described including radio opaque dyes, fluorescent dyes, as well as, colormetric dyes (see e.g., U.S. Pat. Nos. 5,699,798; 5,279,298; 6,351,663; and U.S. patent application Ser. No. 10/365,028). Imaging techniques and systems using fluorescent dyes have been described for the heart and eye (see, U.S. Pat. No. 5,279,298; U.S. patent application Ser.
- Organ transplant is one area in which imaging methods and systems would prove useful.
- the demand for organ transplant continues to grow.
- the combined number of solid organ transplants in the US alone, is approximately 18,000 per year.
- the combined numbers for years 1997 and 1998 were: 1,692 lung transplants, 4,409 heart, 7,502 liver, 326 pancreas, 1,803 pancreas and kidney, and 20,956 kidney transplants (see, e.g., The U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients Annual Report, 2004).
- Transplant procedures involve anastomosis. These anastomoses may be between, for example, two vessels, vessels and duct(s), two ducts, or vessels and ureter(s), two parts of a ureter, or the ureter and bladder.
- solid organ transplant procedures would benefit from the pre-operative assessment of the patency of vessels, ducts, and ureters of the donor organs, and intra-operative and post-operative verification of anastomoses and the patency of blood vessels, ducts, and ureters of the transplanted organs, as well as other recipient blood vessels, ducts, and ureters. It would be particularly useful to provide real time, i.e.
- intra-operative visual confirmation regarding the verification of anastomoses and patency of vessels, e.g. vasculature.
- Traditional intra-operative imaging techniques are frequently ineffective, expensive and inconvenient. The need therefore exists for methods and systems for imaging vessels associated with solid organ transplants which are safe, effective, convenient and cost effective.
- the invention provides a method of intra-operatively determining the patency of at least one vessel which is surgically joined to a transplanted organ in a recipient subject comprising: a) administering a fluorescent dye to the recipient subject; b) applying a sufficient amount of energy to the vessel such that the fluorescent dye fluoresces; c) obtaining a fluorescent image of the vessel surgically joined to a transplanted organ; and d) observing the image to determine if a fluorescent signal is continuous through the vessel, wherein a continuous fluorescent signal in the vessel indicates the vessel is patent.
- the invention provides a portable system useful for imaging at least one vessel which is surgically joined to a transplanted organ in a recipient subject comprising: a) a fluorescent dye; b) an energy source capable of emitting sufficient energy such that the fluorescent dye fluoresces; and c) an imaging head.
- the invention provides a portable system useful for imaging at least one vessel which is surgically joined to a transplanted organ in a recipient subject comprising : a) a fluorescent dye; b) an energy source capable of emitting sufficient energy such that the fluorescent dye fluoresces; c) an imaging head; d) an articulating arm; e) a computer and monitor; f) image processing software; g) an electrical power source; and h) a housing for containing a-g, wherein the housing comprises at least 2 wheels.
- the system may also comprise at least one of the following: a motion sensor; a distance sensor; a sterile drape; and a printer.
- the invention provides a portable apparatus comprising a) an energy source capable of emitting sufficient energy such that a fluorescent dye fluoresces; b) an imaging head; c) an articulating arm; d) a computer and monitor; e) image processing software; f) an electrical power source; and g) a housing for containing a-f, wherein the housing comprises at least 2 wheels.
- the device may also comprise at least one of the following: a motion sensor; a distance sensor; a sterile drape; and a printer.
- FIG. 1 is a schematic diagram showing one embodiment of the system of the invention.
- FIG. 1A shows an example of an electrical configuration.
- FIG. 1B shows an example of an optical configuration.
- Organ transplants of various types are performed routinely. Solid organ transplants of all types require the joining of vessels, e.g., blood vessels in order to attach the donor organ. Some organ transplants, such as a pancreas transplant also require the joining of a duct to a lumen, e.g. the pancreatic duct to the digestive tract. Occlusion, due to, thrombosis, plaque, or free floating endothelial material, for example, is a risk associated with transplant surgery.
- the invention described herein provides a method and a system which a surgeon can use intra-operatively to determine if an anastomosis created during transplant surgery is patent. The invention also provides a method and system to determine, pre-surgery, if a donor organ, or a vessel attached to a donor organ, is patent.
- Subject as used herein refers to any animal.
- the animal may be a mammal.
- suitable mammals include, but are not limited to, humans, non-human primates, dogs, cats, sheep, cows, pigs, horses, mice, rats, rabbits, and guinea pigs.
- Recipient subject refers to a subject that is receiving a solid organ transplant.
- Donor subject refers to a subject that is donating a solid organ for transplant.
- Duct refers to a vessel having a lumen in which a liquid is carried or transported.
- ducts are found for example in liver and in glands, such as sweat glands, or the pancreas.
- the pancreas secretes digestive enzymes via a duct, however, it also secretes insulin from the Islets of Langerhans directly into the blood without any duct.
- Arterial graft refers to a natural or synthetic vessel, which delivers blood to a transplanted solid organ. It can be derived from the donor subject, the recipient subject, or a different subject. It can include a vessel made from a synthetic material, or a naturally derived material (i.e. from a living organism) or a combination of a natural and synthetic material.
- Venous graft refers to a natural or synthetic vessel, which drains blood from a transplanted solid organ. It can be derived from the donor subject, the recipient subject, or a different subject. It can include a vessel made from a synthetic material, or a naturally derived material (i.e. from a living organism) or a combination of a natural and synthetic material.
- Vessel as used herein includes any tube having a lumen capable of transporting a fluid within a subject e.g., veins, arteries and ducts.
- the invention provides a method of intra-operatively determining the patency of at least one vessel, or at least one anastomosis between two vessels, or at least one anastomosis between a vessel and an intervening duct or vessel of an organ, or at least one anastomosis between a vessel and an organ, where the vessel is surgically joined to a transplanted organ in a recipient subject.
- the method comprises comprises administering a fluorescent dye to the subject and exposing at least one of the transplanted organ, the vessel, and the anastomosis, to a form of radiant energy, such that the fluorescent dye fluoresces and obtaining an image of at least one of the vessel, the anastomosis, and the transplanted solid organ.
- the image may be obtained intra-operatively.
- the vessel may be a surgically exposed vessel which communicates with the transplanted organ.
- the invention also contemplates, in some embodiments, obtaining a plurality of images.
- the plurality of images may be compared to each other to determine the effectiveness of a therapy, e.g. an administered pharmaceutical compound, a surgical procedure.
- the invention provides a method for determining the patency of a vessel attached to a donor organ, or determining the patency of a donor organ itself.
- the method comprises a) administering a fluorescent dye to the donor subject or donor organ; b) applying a sufficient amount of energy to the donor organ and attached vessel such that the fluorescent dye fluoresces; c) obtaining a fluorescent image of the donor organ, or a fluorescent image of the vessel attached to the donor organ; and d) observing the image to determine if a fluorescent signal is continuous through the donor organ or the vessel attached to the donor organ, wherein a continuous fluorescent signal in the vessel, or the organ indicates the vessel is patent.
- the invention provides a method of determining the patency of a vessel comprising a lumen.
- patency may be determined by visually inspecting an image of the vessel.
- a continuous signal from a dye that is uniform in thickness may indicate patency.
- an image displaying jagged edges, or a change in thickness may indicate stenosis.
- a discontinuous signal may indicate occlusion.
- the method of the invention may be used in any organ transplant surgery provided at least one vessel from the recipient communicates either directly, or indirectly, e.g., via an intervening vessel, with the transplanted organ, or a vessel attached to the transplanted organ.
- the organ may be a natural organ obtained from a donor subject or man-made synthetic organ, or a combination of the two, i.e., part naturally derived and part synthetic. Transplants involving more than one organ are also contemplated by the invention.
- the vessel may be synthetic, i.e., man-made or natural, i.e. derived from a biological source, including an allograft, an autograft and a xenograft, or a combination of a biological and synthetic source.
- the solid organ transplant may be chosen from a heart, a lung, a liver, a kidney, a pancreas, any combination of heart, lung, pancreas, liver and kidney.
- the organ may be obtained from a living donor or a deceased donor.
- the organ may be a whole organ or a part of an organ.
- liver transplants can involve the transplant of a whole liver, or a part of the liver.
- the method of the invention may be used to determine the patency of any vessel anastomosed to the heart, e.g., inferior vena cava, superior vena cava, atrial cuffs, aortic root, aorta and its branches (e.g., descending aorta, common carotid, subclavian), pulmonary trunk, pulmonary artery, pulmonary vein, or their combined anastomosis to the atrium.
- the transplanted solid organ is a lung
- the method of the invention may be used to determine the patency of any vessel anastomosed to the lung, e.g., pulmonary vein, pulmonary artery.
- the method of the invention may be used to determine the patency of any vessel anastomosed to the liver, e.g., the hepatic artery, the heptatic vein, and branches of either, the portal vein, as well as, the bile duct and its branches.
- the transplanted solid organ is a kidney
- the method of the invention may be used to determine the patency of any vessel anastomosed to the kidney, e.g., the renal artery, the renal vein, the ureter.
- the method of the invention may be used to determine the patency of any vessel anastomosed to the pancreas, e.g., the splenic artery and its branches, the pancreaticoduodenal arteries and its branches, the pancreatic duct.
- the vessel may be an arterial graft or venous graft in any of the solid organ transplants described herein.
- Suitable fluorescent dyes include any non-toxic dye which fluoresces when exposed to radiant energy, e.g. light.
- the dye is a fluorescent dye that emits light in the infra red spectrum.
- the dye is a tricarbocyanine dye such as indocyanine green (ICG).
- ICG indocyanine green
- the dye is selected from fluorescein isothiocyanate, rhodamine, phycoerythrin, phycocyanin, allophycocyanin, o-phthaldehyde, fluorescamine, rose Bengal, trypan blue, and fluoro-gold.
- the aforementioned dyes may be mixed or combined in certain embodiments.
- dye analogs may be used.
- a dye analog includes a dye that has been chemically modified, but still retains its ability to fluoresce when exposed to radiant energy of an appropriate wavelength.
- the dye may be administered intravenously, e.g., as a bolus injection.
- the bolus injection may comprise a volume of about 0.5 ml. In other embodiments the bolus injection may comprise a volume in the range of about 0.1 ml to about 10 ml.
- the dye may be injected into a vein or artery. In yet other embodiments the dye may be injected directly into the transplanted organ. In still other embodiments, the dye is injected within about a 15 cm radius of the transplanted organ. In yet other embodiments the dye may be administered parenterally. Where multiple dyes are used they may be administered simultaneously, e.g. in a single bolus, or sequentially, e.g. in separate boluses. In some embodiments the dye may be administered by a catheter, e.g. during a minimally invasive procedure.
- the dye may be administered at a suitable concentration such that the fluorescence may be detected when the appropriate wavelength of radiant energy is applied.
- a suitable concentration is about 0.03 mg/ml at the site of detection.
- a suitable concentration of ICG is in the range of about 0.003 mg/ml to about 75 mg/ml.
- the ICG is administered in the range of about 1 mg/kg body weight to about 6 mg/kg body weight.
- the dye is administered at a concentration of about 0.5 mg/kg body weight.
- the dye is administered in a range of about 0.01 mg/kg body weight to about 3 mg/kg body weight.
- a suitable maximum daily dose of ICG may be administered to a subject. The maximum daily dose may be in the range of about 70 mg-about 140 mg.
- the dye may be provided as a lyophilized powder or solid. In certain embodiments it may be provided in a vial, e.g. a sterile vial which may permit reconstitution with a sterile syringe. It may be reconstituted using any appropriate carrier or diluent. Examples of carriers and diluents are provided below.
- the dye may be reconstituted at a concentration in the range of about 0.001 mg/ml-100 mg/ml. In other embodiments the dye is reconstituted to a concentration of about 10 mg/ml, about 20 mg/ml, about 30 mg/ml, about 40 mg/ml, about 50 mg/ml.
- the dye may be reconstituted, e.g., with water, immediately before administration.
- the dye may be administered to the subject less than an hour in advance of obtaining an image. In some embodiments the dye may be administered to the subject less than 30 minutes in advance of obtaining an image. In yet other embodiments the dye may be administered at least 30 seconds in advance of obtaining an image. In still other embodiments the dye is administered contemporaneously with obtaining an image.
- any diluent or carrier which will maintain the dye in solution may be used.
- the dye in certain embodiments where the dye is ICG the dye may be reconstituted with water. In other embodiments where the dye is ICG, the dye may be reconstituted with an alcohol, e.g. ethyl alcohol. In some embodiments once the dye is reconstituted it may be mixed with additional diluents and carriers. In some embodiments the dye may be conjugated to another molecule, e.g., a protein, a peptide, an amino acid, a synthetic polymer, or a sugar e.g., to enhance solubility or to enhance stability.
- diluents and carriers which may be used in the invention include glycerin, polyethylene glycol, propylene glycol, polysorbate 80, Tweens, liposomes, amino acids, lecithin, dodecyl sulfate, phospholipids, deoxycholate, soybean oil, vegetable oil, safflower oil, sesame oil, peanut oil, cottonseed oil, sorbitol, acacia, aluminum monostearate, polypxylethylated fatty acids, and mixtures thereof.
- Additional buffering agents may optionally be added including Tris, HCl, NaOH, phosphate buffer, HEPES.
- radiant energy is applied to the transplanted solid organ, or a vessel communicating directly, or indirectly with the solid transplanted organ, in an amount sufficient to cause a fluorescent dye to fluoresce thereby permitting at least one of the transplanted solid organ, or a vessel communicating directly, or indirectly with the solid transplanted organ to be imaged.
- the energy is light energy.
- the source of the light energy is a laser.
- An example of a suitable laser is the Magnum 3000 (Lasiris St-Laurent, Quebec, Canada), however, the skilled artisan will appreciate many other suitable lasers are commercially available.
- the laser may be comprised of a driver and diode.
- the laser may optionally include a filter, e.g.
- the laser may comprise optics for diverging the laser.
- the optics may be adjustable permitting variation in the field of illumination.
- the adjustable optics may also be used to provide even illumination over a given area.
- the laser output is continuous. In other embodiments the laser output is pulsed. The pulsed output may be synchronized with image acquisition by using a pulse generator. In some embodiments the laser pulse may last for at least 3 femtoseconds. In some embodiments the laser output lasts for about 30 seconds. In other embodiments the laser output lasts about 0.5 seconds-about 60 seconds. A suitable repetition rate for the pulsed laser may be in the range of e.g., 1 Hz-80 MHz, 10 Hz-100 Hz, 100 Hz-1 kHz, 1 kHz-100 kHz, 100 kHz-80 MHz. In some embodiments the laser may be operated at power output of 2.2 watts. In other embodiments the laser may be operated at power output in the range of 1-4 watts. In still other embodiments the average power is less than 5 watts.
- the source of the light energy is an incandescent light with an appropriate filter so as to provide a suitable wavelength of light to induce the fluorescent dye to fluoresce.
- the light source is light emitting diode (LED).
- the light energy may have a wavelength in the range of 150 nm-1500 nm. In other embodiments the light energy may be comprised of infra red light. In some embodiments the administered light has a wavelength of about 805 nm. In other embodiments the administered light has a wavelength in the range of about 805 nm-850 nm. The light energy may be administered at a wavelength which is shorter than the collection wavelength, i.e. detection wavelength. The light energy may be administered diffusely so as not to damage the irradiated tissue. In some embodiments the light is administered over an area of about 7.5 cm ⁇ 7.5 cm. In other embodiments the light is administered over an area in the range of about 1 cm. ⁇ 1 cm. to about 20 cm. ⁇ 20 cm.
- Image acquisition may be achieved using any sensor capable of detecting a fluorescent signal.
- Examples include silicon based sensors, composite metal oxide semi oxide (CMOS) sensors and photographic film.
- the sensor comprises a camera, e.g. charge coupled device (CCD).
- CCD charge coupled device
- Examples of a CCD include the Hitachi KP-M2; KP-M3 (Hitachi, Tokyo, Japan).
- an endoscope comprising a sensor may be used.
- the endoscope may additionally comprise a source of radiant energy.
- the endoscope may be comprised of optical fibers.
- a microscope comprising a sensor may be used, e.g., a surgical microscope.
- the sensor comprises a video camera.
- the sensor may capture images at the rate of at least 10 per second, at least 15 per second, at least 20 per second, at least 30 per second, at least 50 per second.
- the invention contemplates a plurality of images. In other embodiments the invention contemplates one image.
- the camera may be comprised of a means for focusing the image.
- the invention contemplates a manual means for focusing an image.
- the invention contemplates an automated means for focusing an image.
- the camera may further be comprised of a lens system that permits magnification of an image field.
- the relative positioning of the camera and laser is fixed so as to enhance clarity and minimize background noise.
- the laser is located at an angle of less than about 85° with respect to the axes of the laser and the camera. In another embodiment the laser is located at an angle from about 200 to about 70° with respect to the axes of the laser and the camera.
- the camera relays the captured image to an analog to digital converter and then through image capture and processing software running on a computer.
- the digital image of the fluorescing agent corresponding to the transplanted organ and/or communicating vessel, may then be displayed on a monitor and recorded by the computer or a peripheral device.
- the image may be stored in any suitable medium, e.g., a hard drive, an optical disk, magnetic tape.
- the camera may also direct images to a television/VCR system such that the images may be displayed in real time, recorded and played back at a later time.
- the invention provides a system for imaging at least one vessel joined to a transplanted solid organ, see, e.g., FIG. 1 .
- the system may be used intra-operatively during transplant surgery to visualize at least one surgically exposed vessel which is joined to the transplanted organ.
- the system comprises: a) a fluorescent dye; b) an energy source capable of emitting sufficient energy such that the fluorescent dye fluoresces; c) an imaging head; d) an articulating arm; e) a computer and monitor; f) image processing software; g) an electrical power source; and h) a housing for containing a-g, wherein the housing is portable and comprises at least 2 wheels.
- the system may also comprise at least one of the following: a motion sensor; a distance sensor; a sterile drape; and a printer.
- the system may further comprise an instruction booklet.
- the system may be portable and thus may be transported in and out of the operating room.
- the system may be self standing and thus does not require to be held by a physician or a technician.
- the imaging head may be comprised of a sensor, e.g., a camera.
- the imaging head may in some embodiments also contain the energy source, e.g. the laser.
- the laser contained within the imaging head provides a nominal ocular hazard distance (NOHD) of about 27 cm.
- NOHD is the distance at which the beam irradiance or radiant exposure equals the corneal maximum permissible exposure.
- the imaging head is joined to the housing by virtue of the articulating arm.
- the articulated arm provides six degrees of freedom for the imaging head.
- the imaging head can be translated and positioned in three linear movements (X,Y and Z), and three angular movements (pitch, yaw and roll).
- Pitch is the rotation of the SPY HEAD about the Y axis.
- Roll is the rotation of the SPY HEAD about the X axis and
- Yaw is the rotation of the SPY HEAD about the Z axis.
- the articulated arm is comprised of three sections, the horizontal section, the articulated section and the yoke.
- the horizontal section attaches to the cart, or housing, and provides movement along the horizontal axis (X axis and also roll) and can move in 270 degrees of freedom.
- the articulated section is hinged in the middle of its length forming two segments. Each segment can rotate with 90 degrees of freedom in one axis.
- the articulated section provides movement in the vertical axis (Z and also X and Y).
- the yoke section is a curved section that attaches to the distal end of the articulated section.
- the yoke has two rotational attachment points. One point attaches to the articulated arm and the other to the imaging head.
- the yoke provides the imaging head two rotational degrees of freedom (pitch and roll).
- the articulating arm thus provides a means for positioning the imaging head directly over the subject.
- the imaging head is positioned above the patient and the appropriate field of view is obtained with the aid of real time images on a computer monitor.
- the physician may adjust the range of focus, e.g., by intermittently observing images on the computer monitor.
- two laser pointers are provided, e.g., one at each end of the imaging head.
- the laser beams may radiate green light.
- the laser beams from the pointers point down toward the patient and provide a means of focusing the camera, without the need to look away from the patient, e.g., at a computer screen. When the two dots from the laser beams converge the centre of the image is determined.
- the device may be provided with buttons that allow for manually turning the laser pointers on and off.
- the buttons may be covered by the sterile drape, but may protrude enough to facilitate ease in switching the laser pointers on and off.
- the computer is a personal computer comprising at least 512 Megabytes of random access memory (RAM) and at least 10 Gigabytes of storage.
- the computer may contain a Pentium IV processor (Intel, Santa Clara, Calif.).
- the computer may also have a CD and DVD drive. The drive may have read and write functionality.
- the system also provides image processing software. In one embodiment the image processing software is FloVisionTM.
- the image processing software permits selection of the optimal image for analysis.
- the image processing software may permit manipulation of contrast.
- the image processing software can permit manipulation of resolution.
- the image processing software can permit manipulation of the number of pixels in a field.
- the image processing software may permit control of the rate at which images are acquired. The software may be able to determine the relative contrast of one image with another, and thus select the images having the greatest contrast for analysis, e.g., images of transplanted organs emitting detectable fluorescence.
- the software may be used to compare images of pre and post treatment vessels to determine flow within the vessel, e.g., blood flow.
- the comparison may be performed by calculating and comparing the area of fluorescence (e.g., the number of pixels associated with the fluorescing dye) in pre and post treatment images corresponding to a selected area of interest in the vessel.
- the relative maximum fluorescent intensity may be calculated, e.g. pre and post-treatment. A greater number of pixels or a greater fluorescent intensity in a post treatment vessel, as compared to a pre-treatment vessel, may be indicative of patency.
- the system also provides, in certain embodiments, a housing to contain the computer, the monitor, the electrical supply, the printer, and the imaging head.
- the housing may be portable to permit movement within the operating room or alternatively to permit movement of the system in and out of the operating room.
- the housing is comprised of at least two wheels. In other embodiments the housing is comprised of four wheels. The wheels may have locks to prevent unwanted movement.
- the housing has a width of about 30 inches, a depth of about 35 inches and height of about 82 inches. In certain embodiments the housing width is less than 45 inches. In certain embodiments the depth is less than 45 inches. In certain embodiments the height is less than 102 inches.
- the housing is not hand held, and thus the system is not required to be hand held.
- the electrical power supply may be comprised of a lock in some embodiments.
- the lock serves as a safety device to prevent inadvertent activation of the system, in particular activation of the laser.
- the system may be comprised of a motion detector.
- the motion detector determines if the imaging head moves.
- the system comprises a distance sensor.
- the distance sensor determines the distance between the imaging head and another object, e.g. the subject.
- it incorporates a visual display which provides feedback to a physician so that the laser and camera may be located at a distance from the tissue of interest that is optimal for capturing high quality images, thereby minimizing the need for focusing the camera during the procedure.
- the system comprises a sterile drape.
- the sterile drape covers the articulating arm to prevent or minimize the risk of contamination of the subject.
- the sterile drape may have an aperture in it.
- the aperture may be covered with a material which is capable of transmitting radiant energy, e.g., infra red light generated by a laser.
- Certain embodiments of the invention provide an apparatus which may be used for intra-operative imaging, e.g., in a surgical suite.
- the apparatus may be portable so that it may be conveniently transported into and out of an operating room.
- the apparatus may be free standing and thus not require a physician, nurse or technician to hold it.
- the apparatus may comprise a) an energy source capable of emitting sufficient energy such that a fluorescent dye fluoresces; b) an imaging head; c) an articulating arm; d) a computer and monitor; e) image processing software; f) an electrical power source; and g) a housing for containing a-f, wherein the housing comprises at least 2 wheels.
- the apparatus may also comprise at least one of the following: a motion sensor; a distance sensor; a sterile drape; and a printer.
- the housing is comprised of at least two wheels. In other embodiments the housing is comprised of four wheels. The wheels may have locks to prevent unwanted movement.
- the apparatus may also comprise a focusing device, e.g., at least one focusing laser, e.g. a first and a second laser pointer, the first laser pointer positioned at a first end of the imaging head, and a second laser pointer positioned at a second end of the imaging head.
- the two laser pointers may be provide radiant light in the green wavelength range and may provide a means of focusing the camera.
- the apparatus may be of a suitable size so that it is free standing, but is small enough so as not to provide a significant obstruction in an operating room.
- the apparatus has a width of about 30 inches, a depth of about 35 inches and height of about 82 inches.
- the apparatus width is less than 45 inches.
- the apparatus depth is less than 45 inches.
- the apparatus height is less than 102 inches.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
Description
- The invention relates generally to the field of medical imaging. Certain embodiments of the invention provide methods for imaging of vasculature in a subject. Certain other embodiments provide systems which are useful for imaging vasculature in a subject.
- Imaging of biological tissues and organs assists doctors in both diagnosis and treatment. A variety of medical techniques which are suitable for imaging biological tissues and organs are known. These include traditional x-rays, ultra-sound, as well as magnetic resonance imaging (MRI), and computerized tomography (CT). A variety of dyes used in medical imaging have also been described including radio opaque dyes, fluorescent dyes, as well as, colormetric dyes (see e.g., U.S. Pat. Nos. 5,699,798; 5,279,298; 6,351,663; and U.S. patent application Ser. No. 10/365,028). Imaging techniques and systems using fluorescent dyes have been described for the heart and eye (see, U.S. Pat. No. 5,279,298; U.S. patent application Ser. Nos. 09/744,034 and 10/619,548, all of which are incorporated by reference in their entirety). Some dyes can serve both an imaging function, as well as a therapeutic function (see, e.g. U.S. Pat. No. 6,840,933).
- Organ transplant is one area in which imaging methods and systems would prove useful. The demand for organ transplant continues to grow. The combined number of solid organ transplants in the US alone, is approximately 18,000 per year. Specifically the combined numbers for years 1997 and 1998 were: 1,692 lung transplants, 4,409 heart, 7,502 liver, 326 pancreas, 1,803 pancreas and kidney, and 20,956 kidney transplants (see, e.g., The U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients Annual Report, 2004).
- Transplant procedures involve anastomosis. These anastomoses may be between, for example, two vessels, vessels and duct(s), two ducts, or vessels and ureter(s), two parts of a ureter, or the ureter and bladder. As such, solid organ transplant procedures would benefit from the pre-operative assessment of the patency of vessels, ducts, and ureters of the donor organs, and intra-operative and post-operative verification of anastomoses and the patency of blood vessels, ducts, and ureters of the transplanted organs, as well as other recipient blood vessels, ducts, and ureters. It would be particularly useful to provide real time, i.e. intra-operative visual confirmation regarding the verification of anastomoses and patency of vessels, e.g. vasculature. Traditional intra-operative imaging techniques, are frequently ineffective, expensive and inconvenient. The need therefore exists for methods and systems for imaging vessels associated with solid organ transplants which are safe, effective, convenient and cost effective.
- In certain embodiments the invention provides a method of intra-operatively determining the patency of at least one vessel which is surgically joined to a transplanted organ in a recipient subject comprising: a) administering a fluorescent dye to the recipient subject; b) applying a sufficient amount of energy to the vessel such that the fluorescent dye fluoresces; c) obtaining a fluorescent image of the vessel surgically joined to a transplanted organ; and d) observing the image to determine if a fluorescent signal is continuous through the vessel, wherein a continuous fluorescent signal in the vessel indicates the vessel is patent.
- In certain embodiments the invention provides a portable system useful for imaging at least one vessel which is surgically joined to a transplanted organ in a recipient subject comprising: a) a fluorescent dye; b) an energy source capable of emitting sufficient energy such that the fluorescent dye fluoresces; and c) an imaging head.
- In certain embodiments the invention provides a portable system useful for imaging at least one vessel which is surgically joined to a transplanted organ in a recipient subject comprising : a) a fluorescent dye; b) an energy source capable of emitting sufficient energy such that the fluorescent dye fluoresces; c) an imaging head; d) an articulating arm; e) a computer and monitor; f) image processing software; g) an electrical power source; and h) a housing for containing a-g, wherein the housing comprises at least 2 wheels. In some embodiments the system may also comprise at least one of the following: a motion sensor; a distance sensor; a sterile drape; and a printer.
- In certain embodiments the invention provides a portable apparatus comprising a) an energy source capable of emitting sufficient energy such that a fluorescent dye fluoresces; b) an imaging head; c) an articulating arm; d) a computer and monitor; e) image processing software; f) an electrical power source; and g) a housing for containing a-f, wherein the housing comprises at least 2 wheels. In some embodiments the device may also comprise at least one of the following: a motion sensor; a distance sensor; a sterile drape; and a printer.
- The above and further advantages of the invention may be better understood by referring to the following description in conjunction with the accompanying drawings in which:
-
FIG. 1 is a schematic diagram showing one embodiment of the system of the invention.FIG. 1A shows an example of an electrical configuration.FIG. 1B shows an example of an optical configuration. - Organ transplants of various types are performed routinely. Solid organ transplants of all types require the joining of vessels, e.g., blood vessels in order to attach the donor organ. Some organ transplants, such as a pancreas transplant also require the joining of a duct to a lumen, e.g. the pancreatic duct to the digestive tract. Occlusion, due to, thrombosis, plaque, or free floating endothelial material, for example, is a risk associated with transplant surgery. The invention described herein, in certain embodiments, provides a method and a system which a surgeon can use intra-operatively to determine if an anastomosis created during transplant surgery is patent. The invention also provides a method and system to determine, pre-surgery, if a donor organ, or a vessel attached to a donor organ, is patent.
- Subject as used herein, refers to any animal. The animal may be a mammal. Examples of suitable mammals include, but are not limited to, humans, non-human primates, dogs, cats, sheep, cows, pigs, horses, mice, rats, rabbits, and guinea pigs.
- Recipient subject, as used herein, refers to a subject that is receiving a solid organ transplant.
- Donor subject, as used herein, refers to a subject that is donating a solid organ for transplant.
- Duct, as used herein, refers to a vessel having a lumen in which a liquid is carried or transported. In some living organisms ducts are found for example in liver and in glands, such as sweat glands, or the pancreas. The pancreas secretes digestive enzymes via a duct, however, it also secretes insulin from the Islets of Langerhans directly into the blood without any duct.
- Arterial graft, as used herein, refers to a natural or synthetic vessel, which delivers blood to a transplanted solid organ. It can be derived from the donor subject, the recipient subject, or a different subject. It can include a vessel made from a synthetic material, or a naturally derived material (i.e. from a living organism) or a combination of a natural and synthetic material.
- Venous graft, as used herein, refers to a natural or synthetic vessel, which drains blood from a transplanted solid organ. It can be derived from the donor subject, the recipient subject, or a different subject. It can include a vessel made from a synthetic material, or a naturally derived material (i.e. from a living organism) or a combination of a natural and synthetic material.
- Vessel as used herein includes any tube having a lumen capable of transporting a fluid within a subject e.g., veins, arteries and ducts.
- Methods of the Invention
- In certain embodiments the invention provides a method of intra-operatively determining the patency of at least one vessel, or at least one anastomosis between two vessels, or at least one anastomosis between a vessel and an intervening duct or vessel of an organ, or at least one anastomosis between a vessel and an organ, where the vessel is surgically joined to a transplanted organ in a recipient subject. The method comprises comprises administering a fluorescent dye to the subject and exposing at least one of the transplanted organ, the vessel, and the anastomosis, to a form of radiant energy, such that the fluorescent dye fluoresces and obtaining an image of at least one of the vessel, the anastomosis, and the transplanted solid organ. The image may be obtained intra-operatively. Thus, in some embodiments, the vessel may be a surgically exposed vessel which communicates with the transplanted organ.
- The invention also contemplates, in some embodiments, obtaining a plurality of images. The plurality of images may be compared to each other to determine the effectiveness of a therapy, e.g. an administered pharmaceutical compound, a surgical procedure.
- In certain embodiments the invention provides a method for determining the patency of a vessel attached to a donor organ, or determining the patency of a donor organ itself. The method comprises a) administering a fluorescent dye to the donor subject or donor organ; b) applying a sufficient amount of energy to the donor organ and attached vessel such that the fluorescent dye fluoresces; c) obtaining a fluorescent image of the donor organ, or a fluorescent image of the vessel attached to the donor organ; and d) observing the image to determine if a fluorescent signal is continuous through the donor organ or the vessel attached to the donor organ, wherein a continuous fluorescent signal in the vessel, or the organ indicates the vessel is patent.
- In certain embodiments the invention provides a method of determining the patency of a vessel comprising a lumen. In some embodiments patency may be determined by visually inspecting an image of the vessel. As an example, but not as a limitation, a continuous signal from a dye that is uniform in thickness may indicate patency. As another non-limiting example an image displaying jagged edges, or a change in thickness may indicate stenosis. Similarly a discontinuous signal may indicate occlusion.
- Solid Organs
- The method of the invention may be used in any organ transplant surgery provided at least one vessel from the recipient communicates either directly, or indirectly, e.g., via an intervening vessel, with the transplanted organ, or a vessel attached to the transplanted organ. The organ may be a natural organ obtained from a donor subject or man-made synthetic organ, or a combination of the two, i.e., part naturally derived and part synthetic. Transplants involving more than one organ are also contemplated by the invention. The vessel may be synthetic, i.e., man-made or natural, i.e. derived from a biological source, including an allograft, an autograft and a xenograft, or a combination of a biological and synthetic source.
- As an example, but not as a limitation, the solid organ transplant may be chosen from a heart, a lung, a liver, a kidney, a pancreas, any combination of heart, lung, pancreas, liver and kidney. The organ may be obtained from a living donor or a deceased donor. The organ may be a whole organ or a part of an organ. For example liver transplants can involve the transplant of a whole liver, or a part of the liver.
- Where the transplanted solid organ is a heart the method of the invention may be used to determine the patency of any vessel anastomosed to the heart, e.g., inferior vena cava, superior vena cava, atrial cuffs, aortic root, aorta and its branches (e.g., descending aorta, common carotid, subclavian), pulmonary trunk, pulmonary artery, pulmonary vein, or their combined anastomosis to the atrium. Where the transplanted solid organ is a lung the method of the invention may be used to determine the patency of any vessel anastomosed to the lung, e.g., pulmonary vein, pulmonary artery. Where the transplanted solid organ is a liver the method of the invention may be used to determine the patency of any vessel anastomosed to the liver, e.g., the hepatic artery, the heptatic vein, and branches of either, the portal vein, as well as, the bile duct and its branches. Where the transplanted solid organ is a kidney the method of the invention may be used to determine the patency of any vessel anastomosed to the kidney, e.g., the renal artery, the renal vein, the ureter. Where the transplanted solid organ is a pancreas the method of the invention may be used to determine the patency of any vessel anastomosed to the pancreas, e.g., the splenic artery and its branches, the pancreaticoduodenal arteries and its branches, the pancreatic duct. The vessel may be an arterial graft or venous graft in any of the solid organ transplants described herein.
- Dyes
- Suitable fluorescent dyes include any non-toxic dye which fluoresces when exposed to radiant energy, e.g. light. In certain embodiments the dye is a fluorescent dye that emits light in the infra red spectrum. In certain embodiments the dye is a tricarbocyanine dye such as indocyanine green (ICG). In other embodiments the dye is selected from fluorescein isothiocyanate, rhodamine, phycoerythrin, phycocyanin, allophycocyanin, o-phthaldehyde, fluorescamine, rose Bengal, trypan blue, and fluoro-gold. The aforementioned dyes may be mixed or combined in certain embodiments. In some embodiments dye analogs may be used. A dye analog includes a dye that has been chemically modified, but still retains its ability to fluoresce when exposed to radiant energy of an appropriate wavelength.
- In some embodiments the dye may be administered intravenously, e.g., as a bolus injection. In some embodiments the bolus injection may comprise a volume of about 0.5 ml. In other embodiments the bolus injection may comprise a volume in the range of about 0.1 ml to about 10 ml. In some embodiments the dye may be injected into a vein or artery. In yet other embodiments the dye may be injected directly into the transplanted organ. In still other embodiments, the dye is injected within about a 15 cm radius of the transplanted organ. In yet other embodiments the dye may be administered parenterally. Where multiple dyes are used they may be administered simultaneously, e.g. in a single bolus, or sequentially, e.g. in separate boluses. In some embodiments the dye may be administered by a catheter, e.g. during a minimally invasive procedure.
- The dye may be administered at a suitable concentration such that the fluorescence may be detected when the appropriate wavelength of radiant energy is applied. In some embodiments where the dye is ICG a suitable concentration is about 0.03 mg/ml at the site of detection. In other embodiments a suitable concentration of ICG is in the range of about 0.003 mg/ml to about 75 mg/ml. In some embodiments the ICG is administered in the range of about 1 mg/kg body weight to about 6 mg/kg body weight. In yet other embodiments the dye is administered at a concentration of about 0.5 mg/kg body weight. In still other embodiments the dye is administered in a range of about 0.01 mg/kg body weight to about 3 mg/kg body weight. In certain embodiments a suitable maximum daily dose of ICG may be administered to a subject. The maximum daily dose may be in the range of about 70 mg-about 140 mg.
- The dye may be provided as a lyophilized powder or solid. In certain embodiments it may be provided in a vial, e.g. a sterile vial which may permit reconstitution with a sterile syringe. It may be reconstituted using any appropriate carrier or diluent. Examples of carriers and diluents are provided below. In certain embodiments the dye may be reconstituted at a concentration in the range of about 0.001 mg/ml-100 mg/ml. In other embodiments the dye is reconstituted to a concentration of about 10 mg/ml, about 20 mg/ml, about 30 mg/ml, about 40 mg/ml, about 50 mg/ml. The dye may be reconstituted, e.g., with water, immediately before administration.
- In certain embodiments the dye may be administered to the subject less than an hour in advance of obtaining an image. In some embodiments the dye may be administered to the subject less than 30 minutes in advance of obtaining an image. In yet other embodiments the dye may be administered at least 30 seconds in advance of obtaining an image. In still other embodiments the dye is administered contemporaneously with obtaining an image.
- Diluents and Carriers
- Any diluent or carrier which will maintain the dye in solution may be used. As an example, in certain embodiments where the dye is ICG the dye may be reconstituted with water. In other embodiments where the dye is ICG, the dye may be reconstituted with an alcohol, e.g. ethyl alcohol. In some embodiments once the dye is reconstituted it may be mixed with additional diluents and carriers. In some embodiments the dye may be conjugated to another molecule, e.g., a protein, a peptide, an amino acid, a synthetic polymer, or a sugar e.g., to enhance solubility or to enhance stability.
- Additional examples of diluents and carriers which may be used in the invention include glycerin, polyethylene glycol, propylene glycol, polysorbate 80, Tweens, liposomes, amino acids, lecithin, dodecyl sulfate, phospholipids, deoxycholate, soybean oil, vegetable oil, safflower oil, sesame oil, peanut oil, cottonseed oil, sorbitol, acacia, aluminum monostearate, polypxylethylated fatty acids, and mixtures thereof. Additional buffering agents may optionally be added including Tris, HCl, NaOH, phosphate buffer, HEPES.
- Radiant Energy
- In certain embodiments of the invention radiant energy is applied to the transplanted solid organ, or a vessel communicating directly, or indirectly with the solid transplanted organ, in an amount sufficient to cause a fluorescent dye to fluoresce thereby permitting at least one of the transplanted solid organ, or a vessel communicating directly, or indirectly with the solid transplanted organ to be imaged. In some embodiments the energy is light energy. In some embodiments the source of the light energy is a laser. An example of a suitable laser is the Magnum 3000 (Lasiris St-Laurent, Quebec, Canada), however, the skilled artisan will appreciate many other suitable lasers are commercially available. The laser may be comprised of a driver and diode. The laser may optionally include a filter, e.g. a bandpass filter, to ensure that the emitted radiation is of a substantially uniform wavelength. The laser may comprise optics for diverging the laser. The optics may be adjustable permitting variation in the field of illumination. The adjustable optics may also be used to provide even illumination over a given area.
- In some embodiments the laser output is continuous. In other embodiments the laser output is pulsed. The pulsed output may be synchronized with image acquisition by using a pulse generator. In some embodiments the laser pulse may last for at least 3 femtoseconds. In some embodiments the laser output lasts for about 30 seconds. In other embodiments the laser output lasts about 0.5 seconds-about 60 seconds. A suitable repetition rate for the pulsed laser may be in the range of e.g., 1 Hz-80 MHz, 10 Hz-100 Hz, 100 Hz-1 kHz, 1 kHz-100 kHz, 100 kHz-80 MHz. In some embodiments the laser may be operated at power output of 2.2 watts. In other embodiments the laser may be operated at power output in the range of 1-4 watts. In still other embodiments the average power is less than 5 watts.
- In some embodiments the source of the light energy is an incandescent light with an appropriate filter so as to provide a suitable wavelength of light to induce the fluorescent dye to fluoresce. In yet other embodiments the light source is light emitting diode (LED).
- In some embodiments the light energy may have a wavelength in the range of 150 nm-1500 nm. In other embodiments the light energy may be comprised of infra red light. In some embodiments the administered light has a wavelength of about 805 nm. In other embodiments the administered light has a wavelength in the range of about 805 nm-850 nm. The light energy may be administered at a wavelength which is shorter than the collection wavelength, i.e. detection wavelength. The light energy may be administered diffusely so as not to damage the irradiated tissue. In some embodiments the light is administered over an area of about 7.5 cm×7.5 cm. In other embodiments the light is administered over an area in the range of about 1 cm.×1 cm. to about 20 cm.×20 cm.
- Image Acquisition
- Image acquisition may be achieved using any sensor capable of detecting a fluorescent signal. Examples include silicon based sensors, composite metal oxide semi oxide (CMOS) sensors and photographic film. In one embodiment the sensor comprises a camera, e.g. charge coupled device (CCD). Examples of a CCD include the Hitachi KP-M2; KP-M3 (Hitachi, Tokyo, Japan).
- In certain embodiments an endoscope comprising a sensor may be used. The endoscope may additionally comprise a source of radiant energy. The endoscope may be comprised of optical fibers. In certain other embodiments a microscope comprising a sensor may be used, e.g., a surgical microscope. In another embodiment the sensor comprises a video camera. In certain embodiments the sensor may capture images at the rate of at least 10 per second, at least 15 per second, at least 20 per second, at least 30 per second, at least 50 per second. Thus in certain embodiments the invention contemplates a plurality of images. In other embodiments the invention contemplates one image.
- The camera may be comprised of a means for focusing the image. In certain embodiments the invention contemplates a manual means for focusing an image. In other embodiments the invention contemplates an automated means for focusing an image. The camera may further be comprised of a lens system that permits magnification of an image field.
- In one embodiment the relative positioning of the camera and laser is fixed so as to enhance clarity and minimize background noise. In this embodiment the laser is located at an angle of less than about 85° with respect to the axes of the laser and the camera. In another embodiment the laser is located at an angle from about 200 to about 70° with respect to the axes of the laser and the camera.
- In certain embodiments the camera relays the captured image to an analog to digital converter and then through image capture and processing software running on a computer. The digital image of the fluorescing agent, corresponding to the transplanted organ and/or communicating vessel, may then be displayed on a monitor and recorded by the computer or a peripheral device. The image may be stored in any suitable medium, e.g., a hard drive, an optical disk, magnetic tape. The camera may also direct images to a television/VCR system such that the images may be displayed in real time, recorded and played back at a later time.
- Systems of the Invention
- In certain embodiments the invention provides a system for imaging at least one vessel joined to a transplanted solid organ, see, e.g.,
FIG. 1 . The system may be used intra-operatively during transplant surgery to visualize at least one surgically exposed vessel which is joined to the transplanted organ. - In certain embodiments, the system comprises: a) a fluorescent dye; b) an energy source capable of emitting sufficient energy such that the fluorescent dye fluoresces; c) an imaging head; d) an articulating arm; e) a computer and monitor; f) image processing software; g) an electrical power source; and h) a housing for containing a-g, wherein the housing is portable and comprises at least 2 wheels. In some embodiments the system may also comprise at least one of the following: a motion sensor; a distance sensor; a sterile drape; and a printer. The system may further comprise an instruction booklet. The system may be portable and thus may be transported in and out of the operating room. The system may be self standing and thus does not require to be held by a physician or a technician.
- The imaging head may be comprised of a sensor, e.g., a camera. The imaging head, may in some embodiments also contain the energy source, e.g. the laser. In some embodiments the laser contained within the imaging head provides a nominal ocular hazard distance (NOHD) of about 27 cm. The NOHD is the distance at which the beam irradiance or radiant exposure equals the corneal maximum permissible exposure. In certain embodiments the imaging head is joined to the housing by virtue of the articulating arm.
- The articulated arm provides six degrees of freedom for the imaging head. The imaging head can be translated and positioned in three linear movements (X,Y and Z), and three angular movements (pitch, yaw and roll). Pitch is the rotation of the SPY HEAD about the Y axis. Roll is the rotation of the SPY HEAD about the X axis and Yaw is the rotation of the SPY HEAD about the Z axis.
- The articulated arm is comprised of three sections, the horizontal section, the articulated section and the yoke. The horizontal section attaches to the cart, or housing, and provides movement along the horizontal axis (X axis and also roll) and can move in 270 degrees of freedom. The articulated section is hinged in the middle of its length forming two segments. Each segment can rotate with 90 degrees of freedom in one axis. The articulated section provides movement in the vertical axis (Z and also X and Y). The yoke section is a curved section that attaches to the distal end of the articulated section. The yoke has two rotational attachment points. One point attaches to the articulated arm and the other to the imaging head. The yoke provides the imaging head two rotational degrees of freedom (pitch and roll). The articulating arm thus provides a means for positioning the imaging head directly over the subject.
- In certain embodiments the imaging head is positioned above the patient and the appropriate field of view is obtained with the aid of real time images on a computer monitor. The physician may adjust the range of focus, e.g., by intermittently observing images on the computer monitor. In another embodiment two laser pointers are provided, e.g., one at each end of the imaging head. The laser beams may radiate green light. The laser beams from the pointers point down toward the patient and provide a means of focusing the camera, without the need to look away from the patient, e.g., at a computer screen. When the two dots from the laser beams converge the centre of the image is determined. The device may be provided with buttons that allow for manually turning the laser pointers on and off. The buttons may be covered by the sterile drape, but may protrude enough to facilitate ease in switching the laser pointers on and off.
- In certain embodiments the computer is a personal computer comprising at least 512 Megabytes of random access memory (RAM) and at least 10 Gigabytes of storage. In some embodiments the computer may contain a Pentium IV processor (Intel, Santa Clara, Calif.). In some embodiments the computer may also have a CD and DVD drive. The drive may have read and write functionality. The system also provides image processing software. In one embodiment the image processing software is FloVision™.
- In certain embodiments the image processing software permits selection of the optimal image for analysis. In some embodiments the image processing software may permit manipulation of contrast. In some embodiments the image processing software can permit manipulation of resolution. In another embodiment the image processing software can permit manipulation of the number of pixels in a field. In another embodiment the image processing software may permit control of the rate at which images are acquired. The software may be able to determine the relative contrast of one image with another, and thus select the images having the greatest contrast for analysis, e.g., images of transplanted organs emitting detectable fluorescence.
- In certain embodiments the software may be used to compare images of pre and post treatment vessels to determine flow within the vessel, e.g., blood flow. The comparison may be performed by calculating and comparing the area of fluorescence (e.g., the number of pixels associated with the fluorescing dye) in pre and post treatment images corresponding to a selected area of interest in the vessel. In other embodiments the relative maximum fluorescent intensity may be calculated, e.g. pre and post-treatment. A greater number of pixels or a greater fluorescent intensity in a post treatment vessel, as compared to a pre-treatment vessel, may be indicative of patency.
- The system also provides, in certain embodiments, a housing to contain the computer, the monitor, the electrical supply, the printer, and the imaging head. The housing may be portable to permit movement within the operating room or alternatively to permit movement of the system in and out of the operating room. In some embodiments the housing is comprised of at least two wheels. In other embodiments the housing is comprised of four wheels. The wheels may have locks to prevent unwanted movement.
- In certain embodiments the housing has a width of about 30 inches, a depth of about 35 inches and height of about 82 inches. In certain embodiments the housing width is less than 45 inches. In certain embodiments the depth is less than 45 inches. In certain embodiments the height is less than 102 inches. The housing is not hand held, and thus the system is not required to be hand held.
- The electrical power supply may be comprised of a lock in some embodiments. The lock serves as a safety device to prevent inadvertent activation of the system, in particular activation of the laser.
- In some embodiments the system may be comprised of a motion detector. The motion detector determines if the imaging head moves. In certain embodiments the system comprises a distance sensor. The distance sensor determines the distance between the imaging head and another object, e.g. the subject. In some embodiments it incorporates a visual display which provides feedback to a physician so that the laser and camera may be located at a distance from the tissue of interest that is optimal for capturing high quality images, thereby minimizing the need for focusing the camera during the procedure.
- In some embodiments the system comprises a sterile drape. The sterile drape covers the articulating arm to prevent or minimize the risk of contamination of the subject. The sterile drape may have an aperture in it. The aperture may be covered with a material which is capable of transmitting radiant energy, e.g., infra red light generated by a laser.
- Apparatus
- Certain embodiments of the invention provide an apparatus which may be used for intra-operative imaging, e.g., in a surgical suite. The apparatus may be portable so that it may be conveniently transported into and out of an operating room. The apparatus may be free standing and thus not require a physician, nurse or technician to hold it. The apparatus may comprise a) an energy source capable of emitting sufficient energy such that a fluorescent dye fluoresces; b) an imaging head; c) an articulating arm; d) a computer and monitor; e) image processing software; f) an electrical power source; and g) a housing for containing a-f, wherein the housing comprises at least 2 wheels. In some embodiments the apparatus may also comprise at least one of the following: a motion sensor; a distance sensor; a sterile drape; and a printer. In some embodiments the housing is comprised of at least two wheels. In other embodiments the housing is comprised of four wheels. The wheels may have locks to prevent unwanted movement. The apparatus may also comprise a focusing device, e.g., at least one focusing laser, e.g. a first and a second laser pointer, the first laser pointer positioned at a first end of the imaging head, and a second laser pointer positioned at a second end of the imaging head. The two laser pointers may be provide radiant light in the green wavelength range and may provide a means of focusing the camera.
- The apparatus may be of a suitable size so that it is free standing, but is small enough so as not to provide a significant obstruction in an operating room. In certain embodiments the apparatus has a width of about 30 inches, a depth of about 35 inches and height of about 82 inches. In certain embodiments the apparatus width is less than 45 inches. In certain embodiments the apparatus depth is less than 45 inches. In certain embodiments the apparatus height is less than 102 inches.
- Many modifications and variations of this invention can be made without departing from its spirit and scope, as will be apparent to those skilled in the art. The specific embodiments described herein are offered by way of example only and are not meant to be limiting in any way. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being indicated by the following claims.
Claims (67)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/114,501 US20060239921A1 (en) | 2005-04-26 | 2005-04-26 | Real time vascular imaging during solid organ transplant |
PCT/US2006/016089 WO2006121631A2 (en) | 2005-04-26 | 2006-04-26 | Real time imaging during solid organ transplant |
US11/912,877 US8647605B2 (en) | 2005-04-26 | 2006-04-26 | Real time imaging during solid organ transplant |
US14/177,045 US9421280B2 (en) | 2005-04-26 | 2014-02-10 | Real time imaging during solid organ transplant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/114,501 US20060239921A1 (en) | 2005-04-26 | 2005-04-26 | Real time vascular imaging during solid organ transplant |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/016089 Continuation WO2006121631A2 (en) | 2005-04-26 | 2006-04-26 | Real time imaging during solid organ transplant |
US11/912,877 Continuation US8647605B2 (en) | 2005-04-26 | 2006-04-26 | Real time imaging during solid organ transplant |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060239921A1 true US20060239921A1 (en) | 2006-10-26 |
Family
ID=37187148
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/114,501 Abandoned US20060239921A1 (en) | 2005-04-26 | 2005-04-26 | Real time vascular imaging during solid organ transplant |
US11/912,877 Active 2029-02-11 US8647605B2 (en) | 2005-04-26 | 2006-04-26 | Real time imaging during solid organ transplant |
US14/177,045 Active 2025-11-24 US9421280B2 (en) | 2005-04-26 | 2014-02-10 | Real time imaging during solid organ transplant |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/912,877 Active 2029-02-11 US8647605B2 (en) | 2005-04-26 | 2006-04-26 | Real time imaging during solid organ transplant |
US14/177,045 Active 2025-11-24 US9421280B2 (en) | 2005-04-26 | 2014-02-10 | Real time imaging during solid organ transplant |
Country Status (2)
Country | Link |
---|---|
US (3) | US20060239921A1 (en) |
WO (1) | WO2006121631A2 (en) |
Cited By (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090054767A1 (en) * | 2007-03-14 | 2009-02-26 | Nicholas Alexander Telischak | Surgical method and apparatus for identification of fluorescence |
US20090192349A1 (en) * | 2008-01-24 | 2009-07-30 | Lifeguard Surgical Systems | Common bile duct surgical imaging system |
US20090203994A1 (en) * | 2005-04-26 | 2009-08-13 | Novadaq Technologies Inc. | Method and apparatus for vasculature visualization with applications in neurosurgery and neurology |
US20090236541A1 (en) * | 2008-03-24 | 2009-09-24 | General Electric Company | System and Methods for Optical Imaging |
US20130053690A1 (en) * | 1999-09-24 | 2013-02-28 | John C. Docherty | Method and Apparatus for Performing Intra-Operative Angiography |
US8880185B2 (en) | 2010-06-11 | 2014-11-04 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US8939970B2 (en) | 2004-09-10 | 2015-01-27 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US8951251B2 (en) | 2011-11-08 | 2015-02-10 | Boston Scientific Scimed, Inc. | Ostial renal nerve ablation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9028472B2 (en) | 2011-12-23 | 2015-05-12 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9125667B2 (en) | 2004-09-10 | 2015-09-08 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
US9125666B2 (en) | 2003-09-12 | 2015-09-08 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US9186209B2 (en) | 2011-07-22 | 2015-11-17 | Boston Scientific Scimed, Inc. | Nerve modulation system having helical guide |
US9186210B2 (en) | 2011-10-10 | 2015-11-17 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US9204830B2 (en) | 2005-04-15 | 2015-12-08 | Surgisense Corporation | Surgical instruments with sensors for detecting tissue properties, and system using such instruments |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US20160045619A1 (en) * | 2006-02-24 | 2016-02-18 | Medibeacon, LLC | Methods of using optical agents |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9297845B2 (en) | 2013-03-15 | 2016-03-29 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9327100B2 (en) | 2008-11-14 | 2016-05-03 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9420967B2 (en) | 2013-03-19 | 2016-08-23 | Surgisense Corporation | Apparatus, systems and methods for determining tissue oxygenation |
US9421280B2 (en) | 2005-04-26 | 2016-08-23 | Novadaq Technologies Inc. | Real time imaging during solid organ transplant |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9433350B2 (en) | 2009-06-10 | 2016-09-06 | W.O.M. World Of Medicine Gmbh | Imaging system and method for the fluorescence-optical visualization of an object |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9486355B2 (en) | 2005-05-03 | 2016-11-08 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US9579030B2 (en) | 2011-07-20 | 2017-02-28 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
US9610021B2 (en) | 2008-01-25 | 2017-04-04 | Novadaq Technologies Inc. | Method for evaluating blush in myocardial tissue |
US9649156B2 (en) | 2010-12-15 | 2017-05-16 | Boston Scientific Scimed, Inc. | Bipolar off-wall electrode device for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US9808300B2 (en) | 2006-05-02 | 2017-11-07 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9816930B2 (en) | 2014-09-29 | 2017-11-14 | Novadaq Technologies Inc. | Imaging a target fluorophore in a biological material in the presence of autofluorescence |
US9827039B2 (en) | 2013-03-15 | 2017-11-28 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US9877654B2 (en) | 2006-02-07 | 2018-01-30 | Novadaq Technologies Inc. | Near infrared imaging |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
US9907609B2 (en) | 2014-02-04 | 2018-03-06 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US9943365B2 (en) | 2013-06-21 | 2018-04-17 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9968244B2 (en) | 2000-07-14 | 2018-05-15 | Novadaq Technologies ULC | Compact fluorescence endoscopy video system |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US10022182B2 (en) | 2013-06-21 | 2018-07-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US10041042B2 (en) | 2008-05-02 | 2018-08-07 | Novadaq Technologies ULC | Methods for production and use of substance-loaded erythrocytes (S-IEs) for observation and treatment of microvascular hemodynamics |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US10182709B2 (en) | 2002-01-15 | 2019-01-22 | Novadaq Technologies ULC | Filter for use with imaging endoscopes |
US10219742B2 (en) | 2008-04-14 | 2019-03-05 | Novadaq Technologies ULC | Locating and analyzing perforator flaps for plastic and reconstructive surgery |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US10265419B2 (en) | 2005-09-02 | 2019-04-23 | Novadaq Technologies ULC | Intraoperative determination of nerve location |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
US10278585B2 (en) | 2012-06-21 | 2019-05-07 | Novadaq Technologies ULC | Quantification and analysis of angiography and perfusion |
US10293122B2 (en) | 2016-03-17 | 2019-05-21 | Novadaq Technologies ULC | Endoluminal introducer with contamination avoidance |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US10342609B2 (en) | 2013-07-22 | 2019-07-09 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US10434190B2 (en) | 2006-09-07 | 2019-10-08 | Novadaq Technologies ULC | Pre-and-intra-operative localization of penile sentinel nodes |
US10492671B2 (en) | 2009-05-08 | 2019-12-03 | Novadaq Technologies ULC | Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest |
US10543037B2 (en) | 2013-03-15 | 2020-01-28 | Medtronic Ardian Luxembourg S.A.R.L. | Controlled neuromodulation systems and methods of use |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10631746B2 (en) | 2014-10-09 | 2020-04-28 | Novadaq Technologies ULC | Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
US10722300B2 (en) | 2013-08-22 | 2020-07-28 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US10945786B2 (en) | 2013-10-18 | 2021-03-16 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US10992848B2 (en) | 2017-02-10 | 2021-04-27 | Novadaq Technologies ULC | Open-field handheld fluorescence imaging systems and methods |
US20210128937A1 (en) * | 2015-07-28 | 2021-05-06 | Know Bio, Llc | Phototherapeutic light for treatment of pathogens |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US11540720B2 (en) * | 2006-10-06 | 2023-01-03 | Stryker European Operations Limited | Methods, software and systems for imaging |
US12115384B2 (en) | 2021-03-15 | 2024-10-15 | Know Bio, Llc | Devices and methods for illuminating tissue to induce biological effects |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080249400A1 (en) * | 2006-10-06 | 2008-10-09 | University Of Rochester Medical Center | Intraoperative Imaging Of Hepatobiliary Structures |
KR100867977B1 (en) * | 2006-10-11 | 2008-11-10 | 한국과학기술원 | Tissue perfusion analysis apparatus using indocyanine green blood concentration dynamics and tissue perfusion analysis method using the same |
KR100818669B1 (en) * | 2007-03-09 | 2008-04-02 | 한국과학기술원 | Unit perfusion degree measuring device |
US9679215B2 (en) | 2012-01-17 | 2017-06-13 | Leap Motion, Inc. | Systems and methods for machine control |
US12260023B2 (en) | 2012-01-17 | 2025-03-25 | Ultrahaptics IP Two Limited | Systems and methods for machine control |
US10691219B2 (en) | 2012-01-17 | 2020-06-23 | Ultrahaptics IP Two Limited | Systems and methods for machine control |
US8693731B2 (en) | 2012-01-17 | 2014-04-08 | Leap Motion, Inc. | Enhanced contrast for object detection and characterization by optical imaging |
US11493998B2 (en) | 2012-01-17 | 2022-11-08 | Ultrahaptics IP Two Limited | Systems and methods for machine control |
US9070019B2 (en) | 2012-01-17 | 2015-06-30 | Leap Motion, Inc. | Systems and methods for capturing motion in three-dimensional space |
US8638989B2 (en) | 2012-01-17 | 2014-01-28 | Leap Motion, Inc. | Systems and methods for capturing motion in three-dimensional space |
US9501152B2 (en) | 2013-01-15 | 2016-11-22 | Leap Motion, Inc. | Free-space user interface and control using virtual constructs |
US9285893B2 (en) | 2012-11-08 | 2016-03-15 | Leap Motion, Inc. | Object detection and tracking with variable-field illumination devices |
US10609285B2 (en) | 2013-01-07 | 2020-03-31 | Ultrahaptics IP Two Limited | Power consumption in motion-capture systems |
US9465461B2 (en) | 2013-01-08 | 2016-10-11 | Leap Motion, Inc. | Object detection and tracking with audio and optical signals |
US9459697B2 (en) | 2013-01-15 | 2016-10-04 | Leap Motion, Inc. | Dynamic, free-space user interactions for machine control |
US9632658B2 (en) | 2013-01-15 | 2017-04-25 | Leap Motion, Inc. | Dynamic user interactions for display control and scaling responsiveness of display objects |
US9702977B2 (en) | 2013-03-15 | 2017-07-11 | Leap Motion, Inc. | Determining positional information of an object in space |
US10620709B2 (en) | 2013-04-05 | 2020-04-14 | Ultrahaptics IP Two Limited | Customized gesture interpretation |
FR3004350A1 (en) * | 2013-04-12 | 2014-10-17 | Air Liquide | DELIVERANCE OF MEDICAL GAS TO A RECEIVER OF BIOLOGICAL EQUIPMENT |
US9916009B2 (en) | 2013-04-26 | 2018-03-13 | Leap Motion, Inc. | Non-tactile interface systems and methods |
US9747696B2 (en) | 2013-05-17 | 2017-08-29 | Leap Motion, Inc. | Systems and methods for providing normalized parameters of motions of objects in three-dimensional space |
US10281987B1 (en) | 2013-08-09 | 2019-05-07 | Leap Motion, Inc. | Systems and methods of free-space gestural interaction |
US10846942B1 (en) | 2013-08-29 | 2020-11-24 | Ultrahaptics IP Two Limited | Predictive information for free space gesture control and communication |
US9632572B2 (en) | 2013-10-03 | 2017-04-25 | Leap Motion, Inc. | Enhanced field of view to augment three-dimensional (3D) sensory space for free-space gesture interpretation |
US10168873B1 (en) | 2013-10-29 | 2019-01-01 | Leap Motion, Inc. | Virtual interactions for machine control |
US9996797B1 (en) | 2013-10-31 | 2018-06-12 | Leap Motion, Inc. | Interactions with virtual objects for machine control |
US9996638B1 (en) | 2013-10-31 | 2018-06-12 | Leap Motion, Inc. | Predictive information for free space gesture control and communication |
US9613262B2 (en) | 2014-01-15 | 2017-04-04 | Leap Motion, Inc. | Object detection and tracking for providing a virtual device experience |
US9741169B1 (en) | 2014-05-20 | 2017-08-22 | Leap Motion, Inc. | Wearable augmented reality devices with object detection and tracking |
GB201410612D0 (en) * | 2014-06-13 | 2014-07-30 | Tomtom Int Bv | Methods and systems for generating route data |
CN204480228U (en) | 2014-08-08 | 2015-07-15 | 厉动公司 | motion sensing and imaging device |
US9696795B2 (en) | 2015-02-13 | 2017-07-04 | Leap Motion, Inc. | Systems and methods of creating a realistic grab experience in virtual reality/augmented reality environments |
US10429923B1 (en) | 2015-02-13 | 2019-10-01 | Ultrahaptics IP Two Limited | Interaction engine for creating a realistic experience in virtual reality/augmented reality environments |
US11430305B2 (en) | 2016-11-21 | 2022-08-30 | Textspeak Corporation | Notification terminal with text-to-speech amplifier |
WO2019070782A1 (en) * | 2017-10-03 | 2019-04-11 | Research Development Foundation | Systems and methods for coronary occlusion treatment |
US11875012B2 (en) | 2018-05-25 | 2024-01-16 | Ultrahaptics IP Two Limited | Throwable interface for augmented reality and virtual reality environments |
US11589776B2 (en) * | 2018-11-06 | 2023-02-28 | The Regents Of The University Of Colorado | Non-contact breathing activity monitoring and analyzing through thermal and CO2 imaging |
CN111639557B (en) * | 2020-05-15 | 2023-06-20 | 圣点世纪科技股份有限公司 | Intelligent registration feedback method for finger vein image |
Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5438989A (en) * | 1990-08-10 | 1995-08-08 | Hochman; Darryl | Solid tumor, cortical function, and nerve tissue imaging methods and device |
US5465718A (en) * | 1990-08-10 | 1995-11-14 | Hochman; Daryl | Solid tumor, cortical function, and nerve tissue imaging methods and device |
US5699798A (en) * | 1990-08-10 | 1997-12-23 | University Of Washington | Method for optically imaging solid tumor tissue |
US6149671A (en) * | 1995-04-04 | 2000-11-21 | Wound Healings Of Oklahoma | Laser/sensitizer assisted immunotherapy |
US6196226B1 (en) * | 1990-08-10 | 2001-03-06 | University Of Washington | Methods and apparatus for optically imaging neuronal tissue and activity |
US6335429B1 (en) * | 1997-10-10 | 2002-01-01 | Cytovia, Inc. | Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof |
US6351663B1 (en) * | 1999-09-10 | 2002-02-26 | Akorn, Inc. | Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation |
US20030156252A1 (en) * | 2001-10-19 | 2003-08-21 | Morris Robert E. | Macula cover and method |
US20030187349A1 (en) * | 2002-03-29 | 2003-10-02 | Olympus Optical Co., Ltd. | Sentinel lymph node detecting method |
US20030232016A1 (en) * | 2002-04-17 | 2003-12-18 | Russell Heinrich | Nerve identification and sparing method |
US20040109231A1 (en) * | 2002-08-28 | 2004-06-10 | Carl-Zeiss-Stiftung Trading As Carl Zeiss | Microscopy system, microscopy method and a method of treating an aneurysm |
US20040156782A1 (en) * | 2003-02-12 | 2004-08-12 | Akorn, Inc. | Methods of using indocyanine green (ICG) dye |
US6804549B2 (en) * | 2000-04-25 | 2004-10-12 | Fuji Photo Film Co., Ltd. | Sentinel lymph node detection method and system therefor |
US6821946B2 (en) * | 2000-05-10 | 2004-11-23 | University College London | Repair of nerve damage |
US6853857B2 (en) * | 2001-05-01 | 2005-02-08 | Pulsion Medical Systems Ag | Method, device and computer program for determining the blood flow in a tissue or organ region |
US20050069525A1 (en) * | 2001-11-16 | 2005-03-31 | Wiberg Mikael | Nerve repair unit and method of producing it |
US20050107380A1 (en) * | 2000-01-18 | 2005-05-19 | Nimmo Alan J. | Brain, spinal and nerve injury treatment |
US6899675B2 (en) * | 2002-01-15 | 2005-05-31 | Xillix Technologies Corp. | Fluorescence endoscopy video systems with no moving parts in the camera |
US6915154B1 (en) * | 1999-09-24 | 2005-07-05 | National Research Council Of Canada | Method and apparatus for performing intra-operative angiography |
US20050182321A1 (en) * | 2002-03-12 | 2005-08-18 | Beth Israel Deaconess Medical Center | Medical imaging systems |
US20050197583A1 (en) * | 1998-02-11 | 2005-09-08 | Britton Chance | Detection, imaging and characterization of breast tumors |
US20060108509A1 (en) * | 2004-09-09 | 2006-05-25 | Frangioni John V | Systems and methods for multi-modal imaging |
US20060241499A1 (en) * | 2005-02-24 | 2006-10-26 | Irion Klaus M | Multifunctional fluorescence diagnosis system |
US20070203413A1 (en) * | 2003-09-15 | 2007-08-30 | Beth Israel Deaconess Medical Center | Medical Imaging Systems |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4394199A (en) | 1981-09-08 | 1983-07-19 | Agnus Chemical Company | Explosive emulsion composition |
DE3380277D1 (en) | 1982-04-08 | 1989-08-31 | Olympus Optical Co | Endoscope focus state detectors |
JPS5970903A (en) | 1982-10-15 | 1984-04-21 | Olympus Optical Co Ltd | Automatic measuring apparatus of endoscope |
JPS5969721A (en) | 1982-10-15 | 1984-04-20 | Olympus Optical Co Ltd | Endoscope measuring device |
US4619249A (en) | 1985-07-24 | 1986-10-28 | Kim Landry | Transcutaneous intravenous illuminator |
US5178616A (en) | 1988-06-06 | 1993-01-12 | Sumitomo Electric Industries, Ltd. | Method and apparatus for intravascular laser surgery |
US4995396A (en) | 1988-12-08 | 1991-02-26 | Olympus Optical Co., Ltd. | Radioactive ray detecting endoscope |
JP2987816B2 (en) | 1989-01-30 | 1999-12-06 | オリンパス光学工業株式会社 | Fluorescence observation device |
SE8900612D0 (en) | 1989-02-22 | 1989-02-22 | Jonas Johansson | TISSUE CHARACTERIZATION USING A BLOOD-FREE FLUORESCENCE CRITERIA |
KR100190423B1 (en) | 1989-06-06 | 1999-06-01 | 기타지마 요시도시 | Method and device for correcting defects such as emulsion mask |
CN1049781A (en) | 1989-09-02 | 1991-03-13 | 住友电气工业株式会社 | Laser surgery instruments for vascular surgery |
JPH0614921B2 (en) | 1989-09-29 | 1994-03-02 | 浜松ホトニクス株式会社 | Fluorescence observation device for biological tissue |
EP0439018B1 (en) | 1990-01-08 | 1995-11-08 | Ernest Feiler, M.D. | Diagnostic method for checking the blood flow |
US4995398A (en) | 1990-04-30 | 1991-02-26 | Turnidge Patrick A | Coronary angiography imaging system |
US5845639A (en) | 1990-08-10 | 1998-12-08 | Board Of Regents Of The University Of Washington | Optical imaging methods |
JPH04297236A (en) | 1991-03-26 | 1992-10-21 | Toshiba Corp | Digital fluorography system |
CA2042075C (en) | 1991-05-08 | 2001-01-23 | Branko Palcic | Endoscopic imaging system |
JP3297725B2 (en) | 1991-12-09 | 2002-07-02 | 国立循環器病センター総長 | Contrast-enhanced blood vessel high-precision pipe diameter measuring device |
US5279298A (en) | 1992-11-20 | 1994-01-18 | The Johns Hopkins University | Method and apparatus to identify and treat neovascular membranes in the eye |
US5437274A (en) | 1993-02-25 | 1995-08-01 | Gholam A. Peyman | Method of visualizing submicron-size vesicles and particles in blood circulation |
JP3228627B2 (en) | 1993-03-19 | 2001-11-12 | オリンパス光学工業株式会社 | Endoscope image processing device |
WO1996009792A1 (en) | 1993-05-17 | 1996-04-04 | The Johns Hopkins University | Improved visualization of choroidal blood flow and aberrant vascular structures in the eye |
US5394199A (en) | 1993-05-17 | 1995-02-28 | The Johns Hopkins University | Methods and apparatus for improved visualization of choroidal blood flow and aberrant vascular structures in the eye using fluorescent dye angiography |
JPH0765154A (en) | 1993-08-31 | 1995-03-10 | Toshiba Corp | Device and method for quantitatively analyzing blood vessel image |
JPH0779955A (en) | 1993-09-14 | 1995-03-28 | Toshiba Corp | Radiographic apparatus |
JPH07222712A (en) | 1994-02-10 | 1995-08-22 | Olympus Optical Co Ltd | Fluorescent endoscope system |
US5453448A (en) | 1993-12-09 | 1995-09-26 | Pdt Cardiovascular, Inc. | In vivo method for estimating the lipid contant of an atheromatous lesion |
JP3641495B2 (en) | 1994-07-19 | 2005-04-20 | 株式会社日立メディコ | Medical diagnostic imaging equipment |
EP0801534B1 (en) | 1994-09-26 | 2003-12-10 | The Johns Hopkins University | Improved visualization of choroidal blood flow and aberrant vascular structures in the eye |
US5935942A (en) | 1994-12-14 | 1999-08-10 | Zeimer; Ran | Selective and non-invasive visualization or treatment of vasculature |
US5951980A (en) | 1995-01-06 | 1999-09-14 | Leuven Research & Development Vzw | Identification, production and use of new staphylokinase derivatives with reduced immunogenicity |
GB9502065D0 (en) | 1995-02-02 | 1995-03-22 | Nycomed Imaging As | Contrast media |
US6032070A (en) | 1995-06-07 | 2000-02-29 | University Of Arkansas | Method and apparatus for detecting electro-magnetic reflection from biological tissue |
MX9801351A (en) | 1995-08-24 | 1998-07-31 | Purdue Research Foundation | Fluorescence lifetime-based imaging and spectroscopy in tissues and other random media. |
US5836311A (en) | 1995-09-20 | 1998-11-17 | Medtronic, Inc. | Method and apparatus for temporarily immobilizing a local area of tissue |
DE19613342A1 (en) | 1996-04-03 | 1997-10-09 | Philips Patentverwaltung | Automatic image evaluation process |
JPH09305845A (en) | 1996-05-13 | 1997-11-28 | Shibaura Eng Works Co Ltd | Hot vending machine |
US5785965A (en) | 1996-05-15 | 1998-07-28 | The Board Of Trustees Of The Leland Stanford Junior Univ. | VEGF gene transfer into endothelial cells for vascular prosthesis |
JP3896176B2 (en) | 1996-05-21 | 2007-03-22 | 浜松ホトニクス株式会社 | Near-infrared fluorescent tracer and fluorescent imaging method |
JPH09308609A (en) | 1996-05-24 | 1997-12-02 | Canon Inc | Ophthalmologic image processor |
US5851181A (en) | 1996-08-30 | 1998-12-22 | Esc Medical Systems Ltd. | Apparatus for simultaneously viewing and spectrally analyzing a portion of skin |
JP2793989B2 (en) | 1996-09-30 | 1998-09-03 | オリンパス光学工業株式会社 | Rotating filter of light source device for endoscope |
US6293911B1 (en) | 1996-11-20 | 2001-09-25 | Olympus Optical Co., Ltd. | Fluorescent endoscope system enabling simultaneous normal light observation and fluorescence observation in infrared spectrum |
JP3962122B2 (en) | 1996-11-20 | 2007-08-22 | オリンパス株式会社 | Endoscope device |
DE69732696T2 (en) | 1997-01-08 | 2006-04-13 | Biosense Webster, Inc., Diamond Bar | MONITORING MYOCARDIAL REVASCULARIZATION |
JPH10210367A (en) | 1997-01-20 | 1998-08-07 | Olympus Optical Co Ltd | Electronic image-pickup device |
US6122042A (en) | 1997-02-07 | 2000-09-19 | Wunderman; Irwin | Devices and methods for optically identifying characteristics of material objects |
US6081612A (en) | 1997-02-28 | 2000-06-27 | Electro Optical Sciences Inc. | Systems and methods for the multispectral imaging and characterization of skin tissue |
AU737530B2 (en) | 1997-04-17 | 2001-08-23 | Avimo Group Limited | Ocular microcirculation examination and treatment apparatus |
GB9710049D0 (en) | 1997-05-19 | 1997-07-09 | Nycomed Imaging As | Method |
US6280386B1 (en) | 1997-06-16 | 2001-08-28 | The Research Foundation Of The City University Of New York | Apparatus for enhancing the visibility of a luminous object inside tissue and methods for same |
AU7934498A (en) | 1997-06-27 | 1999-01-19 | Toa Medical Electronics Co., Ltd. | Living body inspecting apparatus and noninvasive blood analyzer using the same |
JP3370912B2 (en) | 1997-11-14 | 2003-01-27 | 松下電器産業株式会社 | Imaging device |
WO1999047940A1 (en) | 1998-03-18 | 1999-09-23 | Magnetic Imaging Technologies Incorporated | MR METHODS FOR IMAGING PULMONARY AND CARDIAC VASCULATURE AND EVALUATING BLOOD FLOW USING DISSOLVED POLARIZED 129Xe |
CA2413033A1 (en) | 1998-09-18 | 2000-03-30 | Schering Aktiengesellschaft | Near infrared fluorescent contrast agent and fluorescence imaging |
GB9903394D0 (en) | 1999-02-15 | 1999-04-07 | Avimo Group Limited | Treatment of neovascularization and other eye diseases |
US6167297A (en) | 1999-05-05 | 2000-12-26 | Benaron; David A. | Detecting, localizing, and targeting internal sites in vivo using optical contrast agents |
US6944493B2 (en) | 1999-09-10 | 2005-09-13 | Akora, Inc. | Indocyanine green (ICG) compositions and related methods of use |
AU7106400A (en) | 1999-09-10 | 2001-04-10 | Akorn, Inc. | Fluorescent dye angiography and dye-enhanced photocoagulation |
AU782257B2 (en) | 1999-09-24 | 2005-07-14 | Stryker European Operations Limited | Method and apparatus for performing intra-operative angiography |
US20050182434A1 (en) | 2000-08-11 | 2005-08-18 | National Research Council Of Canada | Method and apparatus for performing intra-operative angiography |
US6443976B1 (en) | 1999-11-30 | 2002-09-03 | Akorn, Inc. | Methods for treating conditions and illnesses associated with abnormal vasculature |
US6447443B1 (en) | 2001-01-13 | 2002-09-10 | Medtronic, Inc. | Method for organ positioning and stabilization |
DE10059070C1 (en) | 2000-11-28 | 2002-02-14 | Pulsion Medical Sys Ag | Device for determining tissue perfusion has source and expansion optics arranged in safety housing so only expanded beam of intensity within safety limits for persons near device emanates |
US20060239921A1 (en) | 2005-04-26 | 2006-10-26 | Novadaq Technologies Inc. | Real time vascular imaging during solid organ transplant |
JP3115958U (en) | 2005-07-15 | 2005-11-24 | 株式会社北紋建設 | Fuel reformer |
US11540720B2 (en) | 2006-10-06 | 2023-01-03 | Stryker European Operations Limited | Methods, software and systems for imaging |
-
2005
- 2005-04-26 US US11/114,501 patent/US20060239921A1/en not_active Abandoned
-
2006
- 2006-04-26 WO PCT/US2006/016089 patent/WO2006121631A2/en active Application Filing
- 2006-04-26 US US11/912,877 patent/US8647605B2/en active Active
-
2014
- 2014-02-10 US US14/177,045 patent/US9421280B2/en active Active
Patent Citations (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5438989A (en) * | 1990-08-10 | 1995-08-08 | Hochman; Darryl | Solid tumor, cortical function, and nerve tissue imaging methods and device |
US5465718A (en) * | 1990-08-10 | 1995-11-14 | Hochman; Daryl | Solid tumor, cortical function, and nerve tissue imaging methods and device |
US5699798A (en) * | 1990-08-10 | 1997-12-23 | University Of Washington | Method for optically imaging solid tumor tissue |
US6196226B1 (en) * | 1990-08-10 | 2001-03-06 | University Of Washington | Methods and apparatus for optically imaging neuronal tissue and activity |
US6233480B1 (en) * | 1990-08-10 | 2001-05-15 | University Of Washington | Methods and apparatus for optically imaging neuronal tissue and activity |
US6241672B1 (en) * | 1990-08-10 | 2001-06-05 | University Of Washington | Method and apparatus for optically imaging solid tumor tissue |
US6149671A (en) * | 1995-04-04 | 2000-11-21 | Wound Healings Of Oklahoma | Laser/sensitizer assisted immunotherapy |
US6335429B1 (en) * | 1997-10-10 | 2002-01-01 | Cytovia, Inc. | Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof |
US20050197583A1 (en) * | 1998-02-11 | 2005-09-08 | Britton Chance | Detection, imaging and characterization of breast tumors |
US6351663B1 (en) * | 1999-09-10 | 2002-02-26 | Akorn, Inc. | Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation |
US6915154B1 (en) * | 1999-09-24 | 2005-07-05 | National Research Council Of Canada | Method and apparatus for performing intra-operative angiography |
US20050107380A1 (en) * | 2000-01-18 | 2005-05-19 | Nimmo Alan J. | Brain, spinal and nerve injury treatment |
US6804549B2 (en) * | 2000-04-25 | 2004-10-12 | Fuji Photo Film Co., Ltd. | Sentinel lymph node detection method and system therefor |
US6821946B2 (en) * | 2000-05-10 | 2004-11-23 | University College London | Repair of nerve damage |
US6853857B2 (en) * | 2001-05-01 | 2005-02-08 | Pulsion Medical Systems Ag | Method, device and computer program for determining the blood flow in a tissue or organ region |
US20030156252A1 (en) * | 2001-10-19 | 2003-08-21 | Morris Robert E. | Macula cover and method |
US20050069525A1 (en) * | 2001-11-16 | 2005-03-31 | Wiberg Mikael | Nerve repair unit and method of producing it |
US6899675B2 (en) * | 2002-01-15 | 2005-05-31 | Xillix Technologies Corp. | Fluorescence endoscopy video systems with no moving parts in the camera |
US20050182321A1 (en) * | 2002-03-12 | 2005-08-18 | Beth Israel Deaconess Medical Center | Medical imaging systems |
US20030187349A1 (en) * | 2002-03-29 | 2003-10-02 | Olympus Optical Co., Ltd. | Sentinel lymph node detecting method |
US20030232016A1 (en) * | 2002-04-17 | 2003-12-18 | Russell Heinrich | Nerve identification and sparing method |
US20040109231A1 (en) * | 2002-08-28 | 2004-06-10 | Carl-Zeiss-Stiftung Trading As Carl Zeiss | Microscopy system, microscopy method and a method of treating an aneurysm |
US20040156782A1 (en) * | 2003-02-12 | 2004-08-12 | Akorn, Inc. | Methods of using indocyanine green (ICG) dye |
US20070203413A1 (en) * | 2003-09-15 | 2007-08-30 | Beth Israel Deaconess Medical Center | Medical Imaging Systems |
US20060108509A1 (en) * | 2004-09-09 | 2006-05-25 | Frangioni John V | Systems and methods for multi-modal imaging |
US20060241499A1 (en) * | 2005-02-24 | 2006-10-26 | Irion Klaus M | Multifunctional fluorescence diagnosis system |
Cited By (139)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130053690A1 (en) * | 1999-09-24 | 2013-02-28 | John C. Docherty | Method and Apparatus for Performing Intra-Operative Angiography |
US8892190B2 (en) * | 1999-09-24 | 2014-11-18 | National Research Council Of Canada | Method and apparatus for performing intra-operative angiography |
US9968244B2 (en) | 2000-07-14 | 2018-05-15 | Novadaq Technologies ULC | Compact fluorescence endoscopy video system |
US10182709B2 (en) | 2002-01-15 | 2019-01-22 | Novadaq Technologies ULC | Filter for use with imaging endoscopes |
US9510901B2 (en) | 2003-09-12 | 2016-12-06 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation |
US10188457B2 (en) | 2003-09-12 | 2019-01-29 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation |
US9125666B2 (en) | 2003-09-12 | 2015-09-08 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9125667B2 (en) | 2004-09-10 | 2015-09-08 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
US8939970B2 (en) | 2004-09-10 | 2015-01-27 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US10231634B2 (en) | 2005-04-15 | 2019-03-19 | Surgisense Corporation | Surgical instruments with sensors for detecting tissue properties, and system using such instruments |
US11517213B2 (en) | 2005-04-15 | 2022-12-06 | Surgisense Corporation | Surgical instruments with sensors for detecting tissue properties, and system using such instruments |
US9204830B2 (en) | 2005-04-15 | 2015-12-08 | Surgisense Corporation | Surgical instruments with sensors for detecting tissue properties, and system using such instruments |
US11324412B2 (en) | 2005-04-15 | 2022-05-10 | Surgisense Coporation | Surgical instruments with sensors for detecting tissue properties, and system using such instruments |
US8185176B2 (en) * | 2005-04-26 | 2012-05-22 | Novadaq Technologies, Inc. | Method and apparatus for vasculature visualization with applications in neurosurgery and neurology |
US20090203994A1 (en) * | 2005-04-26 | 2009-08-13 | Novadaq Technologies Inc. | Method and apparatus for vasculature visualization with applications in neurosurgery and neurology |
US9421280B2 (en) | 2005-04-26 | 2016-08-23 | Novadaq Technologies Inc. | Real time imaging during solid organ transplant |
US9486355B2 (en) | 2005-05-03 | 2016-11-08 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US10265419B2 (en) | 2005-09-02 | 2019-04-23 | Novadaq Technologies ULC | Intraoperative determination of nerve location |
US9877654B2 (en) | 2006-02-07 | 2018-01-30 | Novadaq Technologies Inc. | Near infrared imaging |
US20190022256A1 (en) * | 2006-02-24 | 2019-01-24 | Medibeacon Inc. | Methods of using optical agents |
US11351274B2 (en) * | 2006-02-24 | 2022-06-07 | Medibeacon Inc. | Methods of using optical agents |
US10137207B2 (en) * | 2006-02-24 | 2018-11-27 | Medibeacon, Inc. | Methods of using optical agents |
US11185597B2 (en) | 2006-02-24 | 2021-11-30 | Medibeacon, Inc. | Process for using optical agents |
US10695445B2 (en) * | 2006-02-24 | 2020-06-30 | Medibeacon Inc. | Methods of using optical agents |
US20160045619A1 (en) * | 2006-02-24 | 2016-02-18 | Medibeacon, LLC | Methods of using optical agents |
US9283288B2 (en) * | 2006-02-24 | 2016-03-15 | Medibeacon, Inc. | Methods of using optical agents |
US9808300B2 (en) | 2006-05-02 | 2017-11-07 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US10434190B2 (en) | 2006-09-07 | 2019-10-08 | Novadaq Technologies ULC | Pre-and-intra-operative localization of penile sentinel nodes |
US11540720B2 (en) * | 2006-10-06 | 2023-01-03 | Stryker European Operations Limited | Methods, software and systems for imaging |
US10213252B2 (en) | 2006-10-18 | 2019-02-26 | Vessix, Inc. | Inducing desirable temperature effects on body tissue |
US12161392B2 (en) | 2006-10-18 | 2024-12-10 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
US10413356B2 (en) | 2006-10-18 | 2019-09-17 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US20090054767A1 (en) * | 2007-03-14 | 2009-02-26 | Nicholas Alexander Telischak | Surgical method and apparatus for identification of fluorescence |
US7996068B2 (en) | 2007-03-14 | 2011-08-09 | The Board Of Trustees Of The Leland Stanford Junior University | Surgical method and apparatus for identification of fluorescence |
US20090192349A1 (en) * | 2008-01-24 | 2009-07-30 | Lifeguard Surgical Systems | Common bile duct surgical imaging system |
US9072445B2 (en) | 2008-01-24 | 2015-07-07 | Lifeguard Surgical Systems Inc. | Common bile duct surgical imaging system |
US9610021B2 (en) | 2008-01-25 | 2017-04-04 | Novadaq Technologies Inc. | Method for evaluating blush in myocardial tissue |
US11564583B2 (en) | 2008-01-25 | 2023-01-31 | Stryker European Operations Limited | Method for evaluating blush in myocardial tissue |
US9936887B2 (en) | 2008-01-25 | 2018-04-10 | Novadaq Technologies ULC | Method for evaluating blush in myocardial tissue |
US10835138B2 (en) | 2008-01-25 | 2020-11-17 | Stryker European Operations Limited | Method for evaluating blush in myocardial tissue |
US20090236541A1 (en) * | 2008-03-24 | 2009-09-24 | General Electric Company | System and Methods for Optical Imaging |
US10219742B2 (en) | 2008-04-14 | 2019-03-05 | Novadaq Technologies ULC | Locating and analyzing perforator flaps for plastic and reconstructive surgery |
US10041042B2 (en) | 2008-05-02 | 2018-08-07 | Novadaq Technologies ULC | Methods for production and use of substance-loaded erythrocytes (S-IEs) for observation and treatment of microvascular hemodynamics |
US9327100B2 (en) | 2008-11-14 | 2016-05-03 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US10492671B2 (en) | 2009-05-08 | 2019-12-03 | Novadaq Technologies ULC | Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest |
US9433350B2 (en) | 2009-06-10 | 2016-09-06 | W.O.M. World Of Medicine Gmbh | Imaging system and method for the fluorescence-optical visualization of an object |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8880185B2 (en) | 2010-06-11 | 2014-11-04 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9848946B2 (en) | 2010-11-15 | 2017-12-26 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9649156B2 (en) | 2010-12-15 | 2017-05-16 | Boston Scientific Scimed, Inc. | Bipolar off-wall electrode device for renal nerve ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US9579030B2 (en) | 2011-07-20 | 2017-02-28 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
US9186209B2 (en) | 2011-07-22 | 2015-11-17 | Boston Scientific Scimed, Inc. | Nerve modulation system having helical guide |
US9186210B2 (en) | 2011-10-10 | 2015-11-17 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US8951251B2 (en) | 2011-11-08 | 2015-02-10 | Boston Scientific Scimed, Inc. | Ostial renal nerve ablation |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
US9174050B2 (en) | 2011-12-23 | 2015-11-03 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9037259B2 (en) | 2011-12-23 | 2015-05-19 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9072902B2 (en) | 2011-12-23 | 2015-07-07 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9402684B2 (en) | 2011-12-23 | 2016-08-02 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9028472B2 (en) | 2011-12-23 | 2015-05-12 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9592386B2 (en) | 2011-12-23 | 2017-03-14 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9186211B2 (en) | 2011-12-23 | 2015-11-17 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US12186055B2 (en) | 2012-06-21 | 2025-01-07 | Stryker Corporation | Quantification and analysis of angiography and perfusion |
US11284801B2 (en) | 2012-06-21 | 2022-03-29 | Stryker European Operations Limited | Quantification and analysis of angiography and perfusion |
US10278585B2 (en) | 2012-06-21 | 2019-05-07 | Novadaq Technologies ULC | Quantification and analysis of angiography and perfusion |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US9297845B2 (en) | 2013-03-15 | 2016-03-29 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
US9827039B2 (en) | 2013-03-15 | 2017-11-28 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US10543037B2 (en) | 2013-03-15 | 2020-01-28 | Medtronic Ardian Luxembourg S.A.R.L. | Controlled neuromodulation systems and methods of use |
US9420967B2 (en) | 2013-03-19 | 2016-08-23 | Surgisense Corporation | Apparatus, systems and methods for determining tissue oxygenation |
US9943365B2 (en) | 2013-06-21 | 2018-04-17 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
US10022182B2 (en) | 2013-06-21 | 2018-07-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
US10342609B2 (en) | 2013-07-22 | 2019-07-09 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10722300B2 (en) | 2013-08-22 | 2020-07-28 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
US12167889B2 (en) | 2013-08-22 | 2024-12-17 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US10945786B2 (en) | 2013-10-18 | 2021-03-16 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US9907609B2 (en) | 2014-02-04 | 2018-03-06 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US10488340B2 (en) | 2014-09-29 | 2019-11-26 | Novadaq Technologies ULC | Imaging a target fluorophore in a biological material in the presence of autofluorescence |
US9816930B2 (en) | 2014-09-29 | 2017-11-14 | Novadaq Technologies Inc. | Imaging a target fluorophore in a biological material in the presence of autofluorescence |
US10631746B2 (en) | 2014-10-09 | 2020-04-28 | Novadaq Technologies ULC | Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography |
US12109429B2 (en) | 2015-07-28 | 2024-10-08 | Know Bio, Llc | Phototherapeutic light for treatment of pathogens |
US20210128937A1 (en) * | 2015-07-28 | 2021-05-06 | Know Bio, Llc | Phototherapeutic light for treatment of pathogens |
US12179035B2 (en) | 2015-07-28 | 2024-12-31 | Know Bio, Llc | Phototherapeutic light for treatment of pathogens |
US10293122B2 (en) | 2016-03-17 | 2019-05-21 | Novadaq Technologies ULC | Endoluminal introducer with contamination avoidance |
US11140305B2 (en) | 2017-02-10 | 2021-10-05 | Stryker European Operations Limited | Open-field handheld fluorescence imaging systems and methods |
US10992848B2 (en) | 2017-02-10 | 2021-04-27 | Novadaq Technologies ULC | Open-field handheld fluorescence imaging systems and methods |
US12028600B2 (en) | 2017-02-10 | 2024-07-02 | Stryker Corporation | Open-field handheld fluorescence imaging systems and methods |
US12115384B2 (en) | 2021-03-15 | 2024-10-15 | Know Bio, Llc | Devices and methods for illuminating tissue to induce biological effects |
Also Published As
Publication number | Publication date |
---|---|
US20090203993A1 (en) | 2009-08-13 |
US9421280B2 (en) | 2016-08-23 |
WO2006121631A2 (en) | 2006-11-16 |
WO2006121631A3 (en) | 2007-01-04 |
US20140308210A1 (en) | 2014-10-16 |
US8647605B2 (en) | 2014-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060239921A1 (en) | Real time vascular imaging during solid organ transplant | |
US11540720B2 (en) | Methods, software and systems for imaging | |
CN101264014B (en) | System for performing intra-operative angiography | |
US6915154B1 (en) | Method and apparatus for performing intra-operative angiography | |
US7881777B2 (en) | Method and apparatus for performing intra-operative angiography | |
US8185176B2 (en) | Method and apparatus for vasculature visualization with applications in neurosurgery and neurology | |
US20080154102A1 (en) | Intraoperative imaging methods | |
Chang et al. | Advances in fluorescence imaging of the cardiovascular system | |
JP7646176B2 (en) | Medical Fluorescence Equipment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NOVADAG TECHNOLOGIES, INC., CANADA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MANGAT, GURPREET;BRZOZOWSKI, LUKASZ;CROFT, RICHARD L.;REEL/FRAME:016526/0073;SIGNING DATES FROM 20050607 TO 20050623 |
|
AS | Assignment |
Owner name: EDWARDS LIFESCIENCES LLC, CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:NOVADAQ TECHNOLOGIES INC.;REEL/FRAME:019075/0543 Effective date: 20070320 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: NOVADAQ TECHNOLOGIES INC., CANADA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:EDWARDS LIFESCIENCES LLC;REEL/FRAME:043355/0077 Effective date: 20070924 |
|
AS | Assignment |
Owner name: NOVADAQ CORP., CANADA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FUNDING IV TRUST (AS SUCCESSOR AGENT TO MIDCAP FINANCIAL TRUST);REEL/FRAME:043786/0344 Effective date: 20170901 Owner name: NOVADAQ TECHNOLOGIES INC., CANADA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FUNDING IV TRUST (AS SUCCESSOR AGENT TO MIDCAP FINANCIAL TRUST);REEL/FRAME:043786/0344 Effective date: 20170901 Owner name: NOVADAQ TECHNOLOGIES INC., CANADA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FINANCIAL TRUST;REEL/FRAME:043788/0799 Effective date: 20170901 Owner name: NOVADAQ CORP., CANADA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FINANCIAL TRUST;REEL/FRAME:043788/0799 Effective date: 20170901 |